Home / Brands / Life Technologies
Life Technologies Recalls
23 recalls on record · September 4, 2013 to April 10, 2024 · Medical Devices
Recalls by year
13
18
19
20
24
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
April 10, 2024Medical DevicesFDA
Life Technologies Corporation recalls Torrent Suite Dx Software versions 5.14 and earlier used in connection with Ion PGM DX Systems-IVD intended for targeted
Hazard: Torrent Suite Dx Software versions 5.14 and earlier used in connection with Ion PGM DX Systems exploitation of the vulnerability by a threat actor may allow them to alter settings, configurations, software, or data on the instrument
September 23, 2020Medical DevicesFDA
Life Technologies Corporation recalls The TaqPath RT-PCR COVID-19 Kit with Applied Biosystem's COVID-19 Interpretive Software v2.0 or v2.2 (used with the Quan
Hazard: COVID-19 Interpretive Software issues that may cause: 1) the risk of invalid or inconclusive tests/false negative and potentially increasing the retesting burden on customers. 2) false positive results due to improper vortexing.
September 23, 2020Medical DevicesFDA
Life Technologies Corporation recalls The TaqPath RT-PCR COVID-19 Kit with Applied Biosystem's COVID-19 Interpretive Software v1.2 for 7500 RTPCR instruments,
Hazard: COVID-19 Interpretive Software issues that may cause: 1) the risk of invalid or inconclusive tests/false negative and potentially increasing the retesting burden on customers. 2) false positive results due to improper vortexing.
April 22, 2020Medical DevicesFDA
Life Technologies Corporation recalls Ion Torrent Dx No Template Control Kit- IVD for detection of DNA and RNA isolated from non-small cell lung cancer (NSCLC
Hazard: Extended Expiration Date prior to clearance
April 22, 2020Medical DevicesFDA
Life Technologies Corporation recalls Oncomine Dx Target Test RNA/DNA Panel- IVD for detection of DNA and RNA isolated from non-small cell lung cancer (NSCLC)
Hazard: Extended Expiration Date prior to clearance
April 22, 2020Medical DevicesFDA
Life Technologies Corporation recalls Oncomine Dx Target Test RNA Control- IVD for detection of DNA and RNA isolated from non-small cell lung cancer (NSCLC) t
Hazard: Extended Expiration Date prior to clearance
April 22, 2020Medical DevicesFDA
Life Technologies Corporation recalls Oncomine Dx Target Test DNA Control-IVD for detection of DNA and RNA isolated from non-small cell lung cancer (NSCLC) tu
Hazard: Extended Expiration Date prior to clearance
November 13, 2019Medical DevicesFDA
Life Technologies Corporation recalls CTSTM Essential 8 Medium
Hazard: Component was not tested by the supplier for adventitious agents
November 13, 2019Medical DevicesFDA
Life Technologies Corporation recalls StemPro¿ MSC SFM CTS"
Hazard: Component was not tested by the supplier for adventitious agents
October 24, 2018Medical DevicesFDA
Life Technologies, Corp. recalls Gibco GlutaMAX Supplement, for In-Vitro Diagnostic Use SKU 35050061
Hazard: Leaky bottles due to a defect in the bottle cap compromising the sterility of the product
October 24, 2018Medical DevicesFDA
Life Technologies, Corp. recalls Gibco Sodium Pyruvate (100 mM) SKU 11360070, for In-Vitro Diagnostic Use
Hazard: Leaky bottles due to a defect in the bottle cap compromising the sterility of the product
October 24, 2018Medical DevicesFDA
Life Technologies, Corp. recalls Gibco DPBS, calcium, magnesium, for In-Vitro Diagnostic Use SKU 14040141
Hazard: Leaky bottles due to a defect in the bottle cap compromising the sterility of the product
October 24, 2018Medical DevicesFDA
Life Technologies, Corp. recalls Gibco MEM Non-Essential Amino Acids Solution (100X) (SKU 11140050), for In-Vitro Diagnostic Use
Hazard: Leaky bottles due to a defect in the bottle cap compromising the sterility of the product
August 1, 2018Medical DevicesFDA
Life Technologies, Corp. recalls Gibco Dulbecco's Modified Eagle Medium (DMEM), high glucose, pyruvate, Model Number 11995123. Tissue and cell culture m
Hazard: It has been determined that the fill port tube seal integrity was compromised during the manufacture of the product lot. This may cause media to leak out of the primary sterile packaging into outer non-sterile dust cover packaging, and subsequently mold may grow in the pooled, leaked media.
August 1, 2018Medical DevicesFDA
Life Technologies, Corp. recalls Gibco RPMI 1640 Medium, Model Number 61870150. Tissue and cell culture medium.
Hazard: It has been determined that the fill port tube seal integrity was compromised during the manufacture of the product lot. This may cause media to leak out of the primary sterile packaging into outer non-sterile dust cover packaging, and subsequently mold may grow in the pooled, leaked media.
August 1, 2018Medical DevicesFDA
Life Technologies, Corp. recalls Gibco Dulbecco's Modified Eagle Medium (DMEM), high glucose, Model Number 11965175. Tissue and cell culture medium.
Hazard: It has been determined that the fill port tube seal integrity was compromised during the manufacture of the product lot. This may cause media to leak out of the primary sterile packaging into outer non-sterile dust cover packaging, and subsequently mold may grow in the pooled, leaked media.
August 1, 2018Medical DevicesFDA
Life Technologies, Corp. recalls Gibco Dulbecco's Modified Eagle Medium (DMEM), high glucose, pyruvate, Model Number 11995115. Tissue and cell culture m
Hazard: It has been determined that the fill port tube seal integrity was compromised during the manufacture of the product lot. This may cause media to leak out of the primary sterile packaging into outer non-sterile dust cover packaging, and subsequently mold may grow in the pooled, leaked media.
August 1, 2018Medical DevicesFDA
Life Technologies, Corp. recalls GIBCO CTS AIM V Serum-Free Media (SFM), Model Number 0870112BK. Tissue and cell culture medium.
Hazard: It has been determined that the fill port tube seal integrity was compromised during the manufacture of the product lot. This may cause media to leak out of the primary sterile packaging into outer non-sterile dust cover packaging, and subsequently mold may grow in the pooled, leaked media.
August 1, 2018Medical DevicesFDA
Life Technologies, Corp. recalls Gibco CTS OpTmizer T Cell Expansion Serum Free Medium, bag format, Model Numbers A1048503 and A1022103. Tissue and cell
Hazard: It has been determined that the fill port tube seal integrity was compromised during the manufacture of the product lot. This may cause media to leak out of the primary sterile packaging into outer non-sterile dust cover packaging, and subsequently mold may grow in the pooled, leaked media.
May 2, 2018Medical DevicesFDA
Life Technologies Corporation recalls Oncomine Dx Target Test, (Model No. A32451), Oncomine Dx Target RNA/DNA Panel (Model No. A32441). A qualitative In Vi
Hazard: The lower concentration of the RNA panel could cause a NO CALL or FALSE NEGATIVE for the reporting of ROS1 fusion. If a physician relies on a false negative result, crizotinib could be improperly excluded from the patient's treatment regimen.
April 25, 2018Medical DevicesFDA
Life Technologies Corporation recalls Human Fetal Hemoglobin (HBF-1) FITC Conjugate
Hazard: Three lots of Human Fetal Hemoglobin FITC Conjugate are displaying high background and unusual bright staining in the controls and patient samples which could potentially lead to erroneous results (i.e. false positives)
April 11, 2018Medical DevicesFDA
Life Technologies Corporation recalls Oncomine Dx Target Test User Guides and Assay Definition File, Model: A32461; UDI: (01)10190302006071(11)170911(10)1.8(2
Hazard: The Oncomine Dx Target Test may report erroneous results when used off-label for samples other than non-small cell lung cancer (NSCLC) tumor specimens.
September 4, 2013Medical DevicesFDA
Life Technologies Corporation recalls HSV 2 Primers, Catalog #18081020. Analyte Specific Reagent. The HSV-2 primer pair is specific for HSV-2 (Herpes Simplex
Hazard: Firm received complaints that HSV-2 primers failed to amplify HSV-2 DNA.